References
1. Li PH, Yeung HHF, Lau CS, Au EYL. Prevalence, Incidence, and
Sensitization Profile of β-lactam Antibiotic Allergy in Hong Kong.JAMA Netw Open. 2020;3(5):e204199.
2. Zhou L, Dhopeshwarkar N, Blumenthal KG, et al. Drug allergies
documented in electronic health records of a large healthcare system.Allergy. 2016;71(9):1305-1313.
3. Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ. Antibiotic
allergy. Lancet. 2019;393(10167):183-198.
4. Mayer-Schönberger V, Ingelsson E. Big Data and medicine: a big deal?J Intern Med. 2018;283(5):418-429.
5. Thong BY, Lucas M, Kang HR, et al. Drug hypersensitivity reactions in
Asia: regional issues and challenges. Asia Pac Allergy.2020;10(1):e8.
6. Mak HWF, Yeung MHY, Wong JCY, Chiang V, Li PH. Differences in
beta-lactam and penicillin allergy: Beyond the West and focusing on
Asia-Pacific. Front Allergy. 2022;3:1059321.
7. Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and Management
of Penicillin Allergy: A Review. JAMA. 2019;321(2):188-199.
8. Li PH, Siew LQC, Thomas I, et al. Beta-lactam allergy in Chinese
patients and factors predicting genuine allergy. World Allergy
Organ J. 2019;12(8):100048.
9. Siew LQC, Li PH, Watts TJ, et al. Identifying Low-Risk Beta-Lactam
Allergy Patients in a UK Tertiary Centre. J Allergy Clin Immunol
Pract. 2019;7(7):2173-2181.e2171.
10. Kan AKC, Hui HKS, Li TS, et al. Comparative Effectiveness, Safety,
and Real-World Outcomes of a Nurse-Led, Protocol-Driven Penicillin
Allergy Evaluation From the Hong Kong Drug Allergy Delabelling
Initiative (HK-DADI). J Allergy Clin Immunol Pract.2023;11(2):474-480 e472.
11. Venturini Díaz M, Vidal Oribe I, D’Elia Torrence D, Hernández
Alfonso P, Alarcón Gallardo E. New Challenges in Drug Allergy: the
Resurgence of Excipients. Curr Treat Options Allergy.2022;9(3):273-291.
12. Li PH, Wagner A, Thomas I, Watts TJ, Rutkowski R, Rutkowski K.
Steroid Allergy: Clinical Features and the Importance of Excipient
Testing in a Diagnostic Algorithm. J Allergy Clin Immunol Pract.2018;6(5):1655-1661.
13. Li PH, Yeung HHF, Lau CS, Au EYL. Excipient allergy and importance
of complete allergy histories. J Allergy Clin Immunol Pract.2020;8(6):2122-2123.
14. Caballero ML, Krantz MS, Quirce S, Phillips EJ, Stone CA, Jr. Hidden
Dangers: Recognizing Excipients as Potential Causes of Drug and Vaccine
Hypersensitivity Reactions. J Allergy Clin Immunol Pract.2021;9(8):2968-2982.
15. Caballero ML, Quirce S. Immediate Hypersensitivity Reactions Caused
by Drug Excipients: A Literature Review. J Investig Allergol Clin
Immunol. 2020;30(2):86-100.
16. Chiang V, Leung ASY, Au EYL, et al. Consensus Statements on the
Approach to COVID-19 Vaccine Allergy Safety in Hong Kong. Front
Allergy. 2021;2.
17. Chiang V, Leung ASY, Au EYL, et al. Updated consensus statements on
COVID-19 Vaccine Allergy Safety in Hong Kong. Asia Pac Allergy.2022;12(1):e8.
18. Kan AKC, Wong TTH, Chiang V, Lau CS, Li PH. Chronic Spontaneous
Urticaria in Hong Kong: Clinical Characteristics, Real-World Practice
and Implications for COVID-19 Vaccination. Allergy Asthma Immunol
Res. 2023;15(1):32-42.
19. Hospital Authority. Hospital Authority Annual Report.
[Internet]. 2018; about 215 p. Available at:
https://www.ha.org.hk/haho/ho/cc/HA_Annual_Report_2020-21_en.pdf.
Accessed Jun 13, 2022.
20. British Medical Association, Royal Pharmaceutical Society. BNF
83. London, United Kindgom: BMJ Group and the Royal Pharmaceutical
Society of Great Britain; 2022.
21. Xin H, Wu P, Wong JY, et al. Hospitalizations and mortality during
the first year of the COVID-19 pandemic in Hong Kong, China: An
observational study. Lancet Reg Health West Pac. 2023;30:100645.
22. Li PH, Chung HY, Lau CS. Epidemiology and outcomes of geriatric and
non-geriatric patients with drug allergy labels in Hong Kong. Hong
Kong Med J. 2021;27(3):192-197.
23. Yuson C, Shakib S, Smith W. Prevalence of drug allergy in South
Australia. Intern Med J. 2022;52(11):1957-1961.
24. Kvedariene V, Sitkauskiene B, Tamasauskiene L, et al. Prevalence of
self-reported drug hypersensitivity reactions among Lithuanian children
and adults. Allergol Immunopathol (Madr). 2019;47(1):32-37.
25. Thong BY, Tan TC. Epidemiology and risk factors for drug allergy.Br J Clin Pharmacol. 2011;71(5):684-700.
26. Macy E, Poon KYT. Self-reported antibiotic allergy incidence and
prevalence: age and sex effects. Am J Med. 2009;122(8):778
e771-777.
27. Stone CA, Jr., Trubiano J, Coleman DT, Rukasin CRF, Phillips EJ. The
challenge of de-labeling penicillin allergy. Allergy.2020;75(2):273-288.
28. Lee TH, Leung TF, Wong G, et al. The unmet provision of allergy
services in Hong Kong impairs capability for allergy
prevention-implications for the Asia Pacific region. Asian Pac J
Allergy Immunol. 2019;37(1):1-8.
29. Cheng VC, Wong SC, Ho PL, Yuen KY. Strategic measures for the
control of surging antimicrobial resistance in Hong Kong and mainland of
China. Emerg Microbes Infect. 2015;4(2):e8.
30. Li PH, Cheng VC, Yip T, Yap DY, Lui SL, Lo WK. Epidemiology and
Clinical Characteristics of Acinetobacter Peritoneal Dialysis-Related
Peritonitis in Hong Kong-With a Perspective on Multi-Drug and Carbapenem
Resistance. Perit Dial Int. 2017;37(2):177-182.
31. Chan SCW, Yeung WWY, Wong JCY, et al. Prevalence and Impact of
Reported Drug Allergies among Rheumatology Patients. Diagnostics
(Basel). 2020;10(11).
32. West RM, Smith CJ, Pavitt SH, et al. ‘Warning: allergic to
penicillin’: association between penicillin allergy status in 2.3
million NHS general practice electronic health records, antibiotic
prescribing and health outcomes. J Antimicrob Chemother.2019;74(7):2075-2082.
33. Mattingly TJ, 2nd, Fulton A, Lumish RA, et al. The Cost of
Self-Reported Penicillin Allergy: A Systematic Review. J Allergy
Clin Immunol Pract. 2018;6(5):1649-1654.e1644.
34. Chiang V, Saha C, Yim J, et al. The Role of the Allergist in
Coronavirus Disease 2019 Vaccine Allergy Safety: A Pilot Study on a
”Hub-and-Spoke” Model for Population-Wide Allergy Service. Ann
Allergy Asthma Immunol. 2022;129(3):308-312.e301.
35. Chiang V, To KKW, Hung IFN, et al. COVID-19 Vaccine Allergy Safety
Track (VAS-Track) pathway: real-world outcomes on vaccination rates and
antibody protection. Asian Pac J Allergy Immunol. 2023.